Lee M Krug

Lee M Krug

UNVERIFIED PROFILE

Are you Lee M Krug?   Register this Author

Register author
Lee M Krug

Lee M Krug

Publications by authors named "Lee M Krug"

Are you Lee M Krug?   Register this Author

86Publications

2359Reads

34Profile Views

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.

J Clin Oncol 2018 08 15;36(23):2386-2394. Epub 2018 Jun 15.

M. Catherine Pietanza, Lee M. Krug, Mark G. Kris, and Charles M. Rudin, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College; Kaitlin M. Woo, Yevgeniva Bensman, Brenda Hurtado, and Martin Fleisher, Memorial Sloan Kettering Cancer Center, New York, NY; Saiama N. Waqar, Washington University School of Medicine in St. Louis, St Louis, MO; Afshin Dowlati, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, OH; Christine L. Hann, Johns Hopkins University, Baltimore; Alice Chen, National Institutes of Health, Bethesda, MD; Alberto Chiappori, H. Lee Moffitt Cancer Center, Tampa, FL; Taofeek K. Owonikoko, Emory University, Atlanta, GA; and Robert J. Cardnell, Junya Fujimoto, Lihong Long, Lixia Diao, Jing Wang, Patricia de Groot, Erik P. Sulman, Ignacio I. Wistuba, John V. Heymach, and Lauren Averett Byers, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.77.7672DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085179PMC
August 2018

Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.

Clin Lung Cancer 2016 09 21;17(5):e121-e129. Epub 2016 Jan 21.

Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.01.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474315PMC
September 2016

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.

J Clin Oncol 2016 08 20;34(23):2761-8. Epub 2016 Jun 20.

Andreas Rimner, Marjorie G. Zauderer, Prasad S. Adusumilli, Preeti K. Parhar, Abraham J. Wu, Kaitlin M. Woo, Ronglai Shen, Michelle S. Ginsberg, Ellen D. Yorke, Kenneth E. Rosenzweig, Valerie W. Rusch, and Lee M. Krug, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center, New York, NY; and Daniel R. Gomez, David C. Rice, and Anne S. Tsao, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.2675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019761PMC
August 2016

Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma.

J Thorac Oncol 2016 Feb 10;11(2):249-55. Epub 2015 Dec 10.

Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.10.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917284PMC
February 2016

The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers.

Oncoimmunology 2015 Jun 19;4(6):e1009285. Epub 2015 Mar 19.

Thoracic Service; Department of Surgery; Memorial Sloan Kettering Cancer Center ; New York, NY, USA ; Center of Cell Engineering; Memorial Sloan Kettering Cancer Center ; New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1009285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485766PMC
June 2015

Non-Small Cell Lung Cancer, Version 6.2015.

J Natl Compr Canc Netw 2015 May;13(5):515-24

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; University of Washington/Seattle Cancer Care Alliance; Huntsman Cancer Institute at the University of Utah; UC San Diego Moores Cancer Center; Fox Chase Cancer Center; University of Colorado Cancer Center; Roswell Park Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; Duke Cancer Institute; Moffitt Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; City of Hope Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Stanford Cancer Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Mayo Clinic Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0071DOI Listing
May 2015

Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation.

Clin Lung Cancer 2014 Nov 21;15(6):405-10. Epub 2014 Jun 21.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2014.06.002DOI Listing
November 2014

Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma.

Int J Radiat Oncol Biol Phys 2014 Oct 26;90(2):394-401. Epub 2014 Jul 26.

Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center; Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2014.05.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560169PMC
October 2014

Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma.

Lung Cancer 2014 Jun 14;84(3):271-4. Epub 2014 Mar 14.

Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.03.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343315PMC
June 2014

Small-cell lung cancers in patients who never smoked cigarettes.

J Thorac Oncol 2014 Jun;9(6):892-6

*Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center; †Department of Medicine, Weill Cornell Medical College; ‡Department of Pathology; and §Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199745PMC
June 2014

The challenge of malignant pleural mesothelioma: new directions.

J Thorac Oncol 2014 Mar;9(3):271-2

*Thoracic Service, Department of Surgery, †Department of Radiation Oncology, and ‡Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000122DOI Listing
March 2014

Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.

J Thorac Oncol 2013 Nov;8(11):1430-3

*Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York; †Department of Medicine, Weill Cornell Medical College, New York, New York; ‡Departments of Pathology, §Surgery, ‖Epidemiology and Biostatistics, ¶Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31829e7ef9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343301PMC
November 2013

Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab.

Cancer Chemother Pharmacol 2013 Aug 28;72(2):453-61. Epub 2013 Jun 28.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical School, 300 East 66th Street, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2219-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653739PMC
August 2013

Pleurectomy/decortication, chemotherapy, and intensity modulated radiation therapy for malignant pleural mesothelioma: rationale for multimodality therapy incorporating lung-sparing surgery.

Ann Cardiothorac Surg 2012 Nov;1(4):487-90

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2225-319X.2012.10.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741800PMC
November 2012

New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment.

Clin Cancer Res 2012 Sep 23;18(17):4485-90. Epub 2012 Jul 23.

Departments of Pathology and Human Oncology & Pathogenesis Program, Surgery, and Cell Biology Program, Memorial Sloan-Kettering Cancer Center, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2375DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432735PMC
September 2012

Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.

Int J Radiat Oncol Biol Phys 2012 Jul 18;83(4):1278-83. Epub 2012 May 18.

Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.09.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359620PMC
July 2012

Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer.

J Thorac Oncol 2012 May;7(5):856-65

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31824c943fDOI Listing
May 2012

Novel therapies in phase II and III trials for malignant pleural mesothelioma.

J Natl Compr Canc Netw 2012 Jan;10(1):42-7

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343316PMC
http://dx.doi.org/10.6004/jnccn.2012.0007DOI Listing
January 2012

A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations.

J Thorac Oncol 2011 Aug;6(8):1435-7

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318223c099DOI Listing
August 2011

The evolution of multimodality therapy for malignant pleural mesothelioma.

Curr Treat Options Oncol 2011 Jun;12(2):163-72

Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-011-0146-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321839PMC
June 2011

Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib.

Clin Cancer Res 2011 Apr 19;17(8):2521-7. Epub 2011 Jan 19.

Gastrointestinal and Thoracic Oncology Services, Division of Solid Tumor Oncology, Department of Medicine and Radiology, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2662DOI Listing
April 2011

A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies.

Cancer Chemother Pharmacol 2010 Nov 18;66(6):1079-85. Epub 2010 Feb 18.

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1265-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945625PMC
November 2010

WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer.

Cancer Immunol Immunother 2010 Oct 8;59(10):1467-79. Epub 2010 Jun 8.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, 1275 York Ave, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-010-0871-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004362PMC
October 2010

Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer.

J Thorac Oncol 2010 Oct;5(10):1623-9

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181ec1531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020424PMC
October 2010

A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors.

Cancer Chemother Pharmacol 2010 Apr 12;65(5):833-8. Epub 2009 Aug 12.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1088-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711187PMC
April 2010

Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer.

Lung Cancer 2010 Feb 19;67(2):216-20. Epub 2009 May 19.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, 1275 York Ave., New York, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2009.04.009DOI Listing
February 2010

Histone deacetylase inhibitors in malignant pleural mesothelioma: preclinical rationale and clinical trials.

J Thorac Oncol 2010 Feb;5(2):275-9

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181c5e366DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052955PMC
February 2010

Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy.

J Thorac Oncol 2009 Jun;4(6):746-50

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York City, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181a5292cDOI Listing
June 2009

Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels.

J Thorac Oncol 2007 Oct;2(10):947-52

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Medical College at Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181560dccDOI Listing
October 2007

Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer.

Cancer 2007 Aug;110(3):599-605

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center and the Weill Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22816DOI Listing
August 2007

A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer.

J Thorac Oncol 2007 Jul;2(7):638-44

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318074bbd0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715043PMC
July 2007

A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors.

Clin Cancer Res 2007 May;13(9):2692-8

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1754DOI Listing
May 2007

Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma.

J Thorac Oncol 2007 Apr;2(4):317-20

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JTO.0000263715.84567.5fDOI Listing
April 2007

A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer.

Cancer 2006 Sep;107(5):1034-41

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and the Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22088
Publisher Site
http://dx.doi.org/10.1002/cncr.22088DOI Listing
September 2006

Pulmonary neuroendocrine tumors: What (little) do we know?

J Natl Compr Canc Netw 2006 Jul;4(6):623-30

Division of Thoracic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/4/6/623.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2006.0051DOI Listing
July 2006

A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors.

Cancer Chemother Pharmacol 2006 May 31;57(5):671-7. Epub 2005 Aug 31.

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-005-0080-xDOI Listing
May 2006

Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.

Cancer 2006 Jan;106(2):366-74

Department of Thoracic Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21640DOI Listing
January 2006

Potential role of histone deacetylase inhibitors in mesothelioma: clinical experience with suberoylanilide hydroxamic acid.

Clin Lung Cancer 2006 Jan;7(4):257-61

Thoracic Oncology Service , Memorial Sloan-Kettering Cancer Center and Joan and Sanford Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2006.n.003DOI Listing
January 2006

An overview of chemotherapy for mesothelioma.

Authors:
Lee M Krug

Hematol Oncol Clin North Am 2005 Dec;19(6):1117-36, vii

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2005.09.010DOI Listing
December 2005

Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma.

Cancer 2005 Nov;104(10):2149-55

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21428DOI Listing
November 2005

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer.

J Clin Oncol 2005 Jun 16;23(17):3923-31. Epub 2005 May 16.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Joan and Sanford Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.14.167
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.14.167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855284PMC
June 2005

Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial.

Cancer 2005 May;103(10):2128-31

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21000DOI Listing
May 2005

Surgery in the management of small cell lung cancer.

J Natl Compr Canc Netw 2004 Mar;2(2):159-62

Division of Thoracic Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2004.0013DOI Listing
March 2004

Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin.

Clin Cancer Res 2004 Feb;10(3):916-23

Thoracic Oncology Service and Laboratory of Tumor Vaccinology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.ccr-03-0101DOI Listing
February 2004

Vaccine therapy for small cell lung cancer.

Authors:
Lee M Krug

Semin Oncol 2004 Feb;31(1 Suppl 1):112-6

Department of Medicine, Memorail Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2003.12.022DOI Listing
February 2004

A phase I trial of perillyl alcohol in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2003 Jun 15;51(6):493-8. Epub 2003 Apr 15.

Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-003-0599-7DOI Listing
June 2003

10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.

Clin Cancer Res 2003 Jun;9(6):2072-8

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University New York, New York 10021, USA.

View Article

Download full-text PDF

Source
June 2003

Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature.

Am J Clin Oncol 2003 Jun;26(3):247-51

Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.COC.0000017782.24458.DDDOI Listing
June 2003

Bcl-2 and bax expression in advanced non-small cell lung cancer: lack of correlation with chemotherapy response or survival in patients treated with docetaxel plus vinorelbine.

Lung Cancer 2003 Feb;39(2):139-43

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0169-5002(02)00443-9DOI Listing
February 2003

Targeting lethal minimal residual disease in small cell lung cancer.

Semin Oncol 2003 Feb;30(1):79-85

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/sonc.2003.50018DOI Listing
February 2003

The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease.

Cancer 2002 Jul;95(1):119-26

Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.10628DOI Listing
July 2002

Trastuzumab in the treatment of non-small cell lung cancer.

Semin Oncol 2002 Feb;29(1 Suppl 4):59-65

Department of Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/sonc.2002.31526DOI Listing
February 2002